Healthspan Economy

ClinicalTrials.gov · NCT05603455 · Unknown status

Effect of Bifidobacterium Adolescentis on Aging in Healthy Adults (45-65 Years)

Registry record

NCT05603455 on ClinicalTrials.gov. The registry's last update to this record was 9 February 2023.

Date checked: . This is the day the Atlas read the registry record; the registry may have changed since.

Verification record

5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked

  • Title as registered Effect of Bifidobacterium Adolescentis on Aging in Healthy Adults (45-65 Years) Checked Source clinicaltrials.gov Brief title as registered. Checked
  • Sponsor Second Affiliated Hospital, Zhejiang University, School of Medicine Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
  • Intervention Bifidobacterium adolescentis; Placebo Checked Source clinicaltrials.gov Intervention names as registered. Checked
  • Primary outcome as registered Aging Ai 3.0 | Fasting glucose in mmol/L | BMI(Body Mass Index)in kg/m^2 BMI | Epigenetic clock | Bone density in g/cm^3 | Triglycerides in mmol/L | Cholesterol in mmol/L | Telomere level | Blood pressure | body fat percentage | Markers for cell senescence Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
  • Status Unknown status Checked Source clinicaltrials.gov Overall status as registered; registry last update 2023-02-09. Checked

Check history: NCT05603455 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.

Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.

As registered

  • Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
  • Phase: Not applicable
  • Status: Unknown status
  • Intervention: Bifidobacterium adolescentis; Placebo
  • Primary outcome: Aging Ai 3.0 | Fasting glucose in mmol/L | BMI(Body Mass Index)in kg/m^2 BMI | Epigenetic clock | Bone density in g/cm^3 | Triglycerides in mmol/L | Cholesterol in mmol/L | Telomere level | Blood pressure | body fat percentage | Markers for cell senescence
  • Countries: China
  • Start: 1 January 2024
  • Completion (estimated): 31 December 2024

Results

No results were posted on the registry on the date checked. The Atlas does not summarize findings.

A trial being registered is not evidence that the intervention works.